in this issue
People & Business :: M&A
Reckitt Benckiser likely to sell pharma business
9:03 AM MDT | October 23, 2013 | Natasha Alperowicz
Consumer goods group Reckitt Benckiser (Slough, UK) is looking at options for its pharmaceuticals business, the company said on Tuesday. “We are commencing a strategic review of the business and will consider all options for maximizing value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014,” the company says. Reckitt Benckiser’s pharma business is essentially its Suboxone drug, which is used to treat addiction to opioids, such as heroin. The United States accounts for more...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee